Acceptance of Nirsevimab for the Prevention of Respiratory Syncytial Virus Infection in Neonates: A Cross-Sectional Survey in Emilia-Romagna, Italy.

Esposito S, Fainardi V, Capra ME, Aricò M, Lanzoni A, Campana BR, Niceforo M, Neglia C, Valletta E, Biasucci G, Perrone S

Open source

DOI
10.3390/vaccines13090896
Published
2025 Aug 23
Container
Vaccines
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/vaccines13090896,
  title = {Acceptance of Nirsevimab for the Prevention of Respiratory Syncytial Virus Infection in Neonates: A Cross-Sectional Survey in Emilia-Romagna, Italy.},
  author = {Esposito S and Fainardi V and Capra ME and Aricò M and Lanzoni A and Campana BR and Niceforo M and Neglia C and Valletta E and Biasucci G and Perrone S},
  year = {2025},
  journal = {Vaccines},
  doi = {10.3390/vaccines13090896},
  url = {https://doi.org/10.3390/vaccines13090896}
}

RIS

TY  - JOUR
TI  - Acceptance of Nirsevimab for the Prevention of Respiratory Syncytial Virus Infection in Neonates: A Cross-Sectional Survey in Emilia-Romagna, Italy.
AU  - Esposito S
AU  - Fainardi V
AU  - Capra ME
AU  - Aricò M
AU  - Lanzoni A
AU  - Campana BR
AU  - Niceforo M
AU  - Neglia C
AU  - Valletta E
AU  - Biasucci G
AU  - Perrone S
PY  - 2025
JO  - Vaccines
DO  - 10.3390/vaccines13090896
UR  - https://doi.org/10.3390/vaccines13090896
ER  - 

APA

S, E., V, F., ME, C., M, A., A, L., BR, C., M, N., C, N., E, V., G, B., & S, P. (2025). Acceptance of Nirsevimab for the Prevention of Respiratory Syncytial Virus Infection in Neonates: A Cross-Sectional Survey in Emilia-Romagna, Italy.. Vaccines. https://doi.org/10.3390/vaccines13090896

Source records